Cargando…

Redox Regulation in Aging Lungs and Therapeutic Implications of Antioxidants in COPD

Mammals, including humans, are aerobic organisms with a mature respiratory system to intake oxygen as a vital source of cellular energy. Despite the essentiality of reactive oxygen species (ROS) as byproducts of aerobic metabolism for cellular homeostasis, excessive ROS contribute to the development...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kiyokawa, Hirofumi, Hoshino, Yuma, Sakaguchi, Kazuhiro, Muro, Shigeo, Yodoi, Junji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8470212/ https://www.ncbi.nlm.nih.gov/pubmed/34573061 http://dx.doi.org/10.3390/antiox10091429

Ejemplares similares

Thioredoxin-1 Protects against Neutrophilic Inflammation and Emphysema Progression in a Mouse Model of Chronic Obstructive Pulmonary Disease Exacerbation
por: Tanabe, Naoya, et al.
Publicado: (2013)

Impact of COPD Exacerbations on Osteoporosis Assessed by Chest CT Scan
por: Kiyokawa, Hirofumi, et al.
Publicado: (2012)

p38 mitogen-activated protein kinase determines the susceptibility to cigarette smoke-induced emphysema in mice
por: Marumo, Satoshi, et al.
Publicado: (2014)

Redox Dysregulation in Aging and COPD: Role of NOX Enzymes and Implications for Antioxidant Strategies
por: Schiffers, Caspar, et al.
Publicado: (2021)

Longitudinal Study of Spatially Heterogeneous Emphysema Progression in Current Smokers with Chronic Obstructive Pulmonary Disease
por: Tanabe, Naoya, et al.
Publicado: (2012)

Relationship between Periodontitis-Related Antibody and Frequent Exacerbations in Chronic Obstructive Pulmonary Disease
por: Takahashi, Tamaki, et al.
Publicado: (2012)

Correction: Longitudinal Study of Spatially Heterogeneous Emphysema Progression in Current Smokers with Chronic Obstructive Pulmonary Disease
por: Tanabe, Naoya, et al.
Publicado: (2012)

Redox regulation of antioxidants, autophagy, and the response to stress: Implications for electrophile therapeutics
por: Levonen, Anna-Liisa, et al.
Publicado: (2014)

Emphysema distribution and annual changes in pulmonary function in male patients with chronic obstructive pulmonary disease
por: Tanabe, Naoya, et al.
Publicado: (2012)

Thioredoxin/Txnip: Redoxisome, as a Redox Switch for the Pathogenesis of Diseases
por: Yoshihara, Eiji, et al.
Publicado: (2014)

Progress in the mechanism and targeted drug therapy for COPD
por: Wang, Cuixue, et al.
Publicado: (2020)

Relationship between peripheral airway function and patient-reported outcomes in COPD: a cross-sectional study
por: Haruna, Akane, et al.
Publicado: (2010)

Geranylgeranylacetone Ameliorates Skin Inflammation by Regulating and Inducing Thioredoxin via the Thioredoxin Redox System
por: Jin, Tiancheng, et al.
Publicado: (2023)

Redox regulation of DUBs and its therapeutic implications in cancer
por: Tyagi, Apoorvi, et al.
Publicado: (2021)

Geroprotectors as a novel therapeutic strategy for COPD, an accelerating aging disease
por: Ito, Kazuhiro, et al.
Publicado: (2012)

Anti-Inflammatory Thioredoxin Family Proteins for Medicare, Healthcare and Aging Care
por: Yodoi, Junji, et al.
Publicado: (2017)

Physiologic (18)F‐FDG muscle uptake in severe COPD: Implications for accurate lung cancer staging
por: Yoshida, Yuma, et al.
Publicado: (2023)

Chemokines in COPD: From Implication to Therapeutic Use
por: Henrot, Pauline, et al.
Publicado: (2019)

Pancreatic β Cell–specific Expression of Thioredoxin, an Antioxidative and Antiapoptotic Protein, Prevents Autoimmune and Streptozotocin-induced Diabetes
por: Hotta, Mizuo, et al.
Publicado: (1998)

Impaired Redox Signaling in Huntington’s Disease: Therapeutic Implications
por: Paul, Bindu D., et al.
Publicado: (2019)

Redox theory of aging: implications for health and disease
por: Go, Young-Mi, et al.
Publicado: (2017)

Statement from the Japanese Respiratory Society: Working diagnosis and initial management of COPD during the COVID-19 pandemic
por: Shibata, Yoko, et al.
Publicado: (2021)

Therapeutic Intervention in Cancer by Isoliquiritigenin from Licorice: A Natural Antioxidant and Redox Regulator
por: Zhang, Zhu, et al.
Publicado: (2022)

Redox biology and therapeutics in chronic lung disease
por: Thannickal, Victor J.
Publicado: (2020)

Methylation-dependent antioxidant-redox imbalance regulates hypertensive kidney injury in aging
por: Pushpakumar, Sathnur, et al.
Publicado: (2020)

Notch signaling in the mammalian respiratory system, specifically the trachea and lungs, in development, homeostasis, regeneration, and disease
por: Kiyokawa, Hirofumi, et al.
Publicado: (2019)

Time to Shift Focus from Oxidative Stress to Redox Regulation in COPD
por: Reynaert, Niki L.
Publicado: (2022)

Antioxidant therapies in COPD
por: Rahman, Irfan
Publicado: (2006)

Systemic Profiles of microRNAs, Redox Balance, and Inflammation in Lung Cancer Patients: Influence of COPD
por: Qin, Liyun, et al.
Publicado: (2021)

Redox mechanisms in age-related lung fibrosis
por: Kurundkar, Ashish, et al.
Publicado: (2016)

Aging-dependent changes in rat heart mitochondrial glutaredoxins—Implications for redox regulation()
por: Gao, Xing-Huang, et al.
Publicado: (2013)

Efficacy of budesonide/glycopyrronium/formoterol metered dose inhaler in patients with COPD: post-hoc analysis from the KRONOS study excluding patients with airway reversibility and high eosinophil counts
por: Muro, Shigeo, et al.
Publicado: (2021)

Pulmonary sarcoidosis with a cavitary lesion in the lung caused by a TNF‐α inhibitor: A case report
por: Hamada, Eriko, et al.
Publicado: (2022)

Methionine restriction - Association with redox homeostasis and implications on aging and diseases
por: Jelleschitz, Julia, et al.
Publicado: (2022)

Deficiency of Thioredoxin Binding Protein-2 (TBP-2) Enhances TGF-β Signaling and Promotes Epithelial to Mesenchymal Transition
por: Masaki, So, et al.
Publicado: (2012)

DNA damage and antioxidant capacity in COPD patients with and without lung cancer
por: dos Santos, Camila Freitas, et al.
Publicado: (2022)

Low serum free light chain is associated with risk of COPD exacerbation
por: Tanimura, Kazuya, et al.
Publicado: (2020)

Corrections to: Efficacy of budesonide/glycopyrronium/formoterol metered dose inhaler in patients with COPD: post-hoc analysis from the KRONOS study excluding patients with airway reversibility and high eosinophil counts
por: Muro, Shigeo, et al.
Publicado: (2021)

Indacaterol/glycopyrronium versus tiotropium or glycopyrronium in long‐acting bronchodilator‐naïve COPD patients: A pooled analysis
por: Muro, Shigeo, et al.
Publicado: (2019)

Redox Balance in Type 2 Diabetes: Therapeutic Potential and the Challenge of Antioxidant-Based Therapy
por: Argaev-Frenkel, Lital, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_552skjorn44a53j1cebj830abp